Filing Flows › Progyny (PGNY) › Guidance history
Progyny (PGNY) guidance history: what it guided and what it reported
Progyny gave guidance in 3 earnings releases on file since May 7, 2026. Of 1 guided period since reported, it met or beat its own guidance once (100%). Revenue: 1 of 1, on average +0.4% against the guided midpoint. Its releases raised guidance 3 times and lowered it 0 times.
Revenue
Met or beat 1 of 1 periods (0 above, 1 within, 0 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q4 2026 | $345M–$365M (Nov 4, 2026) | — | to be reported | — |
| Q3 2026 | $335M–$345M (Aug 6, 2026) | $341M | within the range | +0.4% |
Net income
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q4 2026 | $28.5M–$32.1M (Nov 4, 2026) | — | to be reported | — |
| Q3 2026 | $24.5M–$26.7M (Aug 6, 2026) | — | — | — |
| Q2 2026 | $25.8M–$28.7M (May 7, 2026) | — | — | — |
| FY2026 | $104M–$112M (May 7, 2026) → lowered $105M–$110M (Aug 6, 2026) → raised $107M–$111M (Nov 4, 2026) | — | to be reported | — |
Adjusted EBITDA
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q4 2026 | $57.9M–$62.9M (Nov 4, 2026) | — | to be reported | — |
| Q3 2026 | $56.0M–$59.0M (Aug 6, 2026) | — | — | — |
| Q2 2026 | $58.0M–$62.0M (May 7, 2026) | — | — | — |
| FY2026 | $232M–$244M (May 7, 2026) → lowered $233M–$240M (Aug 6, 2026) → raised $235M–$240M (Nov 4, 2026) | — | to be reported | — |
Adjusted EPS
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q4 2026 | $1.00 (Nov 4, 2026) | — | to be reported | — |
| Q3 2026 | $1.00 (Aug 6, 2026) | — | — | — |
| Q2 2026 | $1.00 (May 7, 2026) | — | — | — |
| FY2026 | $1.00 (May 7, 2026) → reaffirmed $1.00 (Aug 6, 2026) → reaffirmed $1.00 (Nov 4, 2026) | — | to be reported | — |
The latest quarter
Progyny, Q3 2026: revenue $341M (+9% year over year), operating margin 10.3%, net earnings $26.3M, operating cash flow $56.6M. The chart follows the revenue to costs, profit and cash.
Questions
Does Progyny beat its guidance?
Progyny gave guidance in 3 earnings releases on file since May 7, 2026. Of 1 guided period since reported, it met or beat its own guidance once (100%). Revenue: 1 of 1, on average +0.4% against the guided midpoint.
How often does Progyny raise guidance?
Its earnings releases raised guidance 3 times and lowered it 0 times since May 7, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.